英国和爱尔兰共和国儿童及青少年慢性复发性多灶性骨髓炎发病率研究
本研究通过每月调查英国和爱尔兰共和国所有儿科顾问及儿科骨科医生,识别2020年10月至2022年11月新诊断的慢性复发性多灶性骨髓炎(CRMO)患者,共纳入165例确诊病例和20例可能病例。研究估算儿童和青少年CRMO年均发病率为0.65/10万,并描述了人口学、临床表现、检查及初始治疗特征。
要点
- 英国和爱尔兰共和国16岁以下儿童及青少年CRMO年均发病率为0.65/10万。
- 发病高峰年龄为8-10岁,女性发病率约为男性的两倍,男性更易表现为多灶性疾病。
- 80.0%患者接受全身MRI检查,51.1%接受骨活检,初始治疗最常见为非甾体抗炎药(93.9%)和双膦酸盐(44.8%)。
核心结论
- 本研究估算英国和爱尔兰共和国儿童和青少年CRMO年均发病率为0.65/10万。
- 这些发现为持续研究和改善CRMO患者照护建立了重要基线。
研究设计与样本
- 研究于2020年10月至2022年11月期间,对所有儿科顾问和儿科骨科医生进行每月调查,以识别新诊断的CRMO患者。
- 向报告临床医生发送标准化问卷以收集进一步信息。
- surveillance期间共报告288例患者,其中165例确诊病例和20例可能病例纳入分析。
主要发现
- 发病率最高的年龄组为8-10岁。
- 观察到女性与男性发病率约为二比一的差异,且男性患者更可能表现为多灶性疾病。
- 观察到报告锁骨疼痛与腿痛之间呈负相关。
- 80.0%的患者报告接受了全身MRI检查,51.1%接受了骨活检。
- 最常见的初始治疗为非甾体抗炎药(93.9%)和双膦酸盐(44.8%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Chronic recurrent multifocal osteomyelitis (CRMO), also known as chronic non-bacterial osteomyelitis (CNO), is a rare autoinflammatory condition affecting the bones in children and teenagers. The actual incidence of CRMO remains uncertain. The objective of this study was to identify the incidence of CRMO in children and young people under the age of 16 years in the United Kingdom (UK) and Republic of Ireland (ROI). We also aimed to delineate the demographics, clinical presentation, investigations, initial management and healthcare needs for children and adolescents with CRMO. METHODS: We conducted monthly surveys among all paediatric consultants and paediatric orthopaedic surgeons to identify patients newly diagnosed with CRMO between October 2020 and November 2022. A standardized questionnaire was sent to reporting clinicians to collect further information. RESULTS: Over the surveillance period, 288 patients were reported, among which, 165 confirmed and 20 probable cases were included in the analysis. The highest incidences were among 8-10 year-olds. A two-to-one female-to-male difference in incidence was observed, and male patients were more likely to present with multifocal disease. A negative correlation was observed between reporting clavicular and leg pain. Investigation-wise, 80.0% of patients were reported to have undergone whole-body MRI and 51.1% had bone biopsies. The most common initial treatments were NSAIDs (93.9%) and bisphosphonates (44.8%). CONCLUSION: This study estimates an average annual CRMO incidence of 0.65 cases per 100 000 children and adolescents in the UK and ROI. These findings establish a crucial baseline for ongoing research and improvement in the care of individuals with CRMO.
引用
- Chia DT, Toms AP, Sanghrajka A, et al. Incidence of chronic recurrent multifocal osteomyelitis in children and adolescents in the UK and Republic of Ireland. Rheumatology (Oxford). 2025. PMID: 39167099. doi:10.1093/rheumatology/keae447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。